| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/28/2026 | ±4.5% | -1.4% | over-priced |
| 05/22/2026 | ±4.9% | +0.3% | over-priced |
| 03/26/2026 | ±4.1% | -0.8% | over-priced |
| 11/25/2025 | ±5.4% | +3.4% | over-priced |
| 08/29/2025 | ±4.8% | +0.1% | over-priced |
| 05/28/2025 | ±5.3% | -1.4% | over-priced |
| 03/27/2025 | ±4.1% | -0.6% | over-priced |
| 11/22/2024 | ±7.4% | -0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $2.84 | $2.0B | $338M |
| Q1 FY2026 | $1.93 | $1.8B | $231M |
| Q4 FY2025 | — | $2.4B | $368M |
| Q3 FY2025 | $1.96 | $1.9B | $242M |
WSM (WSM) reports in 31 days, with the next report estimated for 11/27/2026. Across the last 8 reports, options priced an average ±5.1% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced WSM's earnings risk. Fundamentals into the print: EPS up 42.0% year-over-year, revenue up 6.7%. QuantLogix's live 5-factor engine currently reads WSM as a buy at 83/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →